Humana Inc. (NYSE:HUM) – Equities researchers at Jefferies Group increased their FY2017 earnings per share (EPS) estimates for Humana in a research report issued on Tuesday. Jefferies Group analyst D. Windley now anticipates that the brokerage will post earnings per share of $11.16 for the year, up from their prior forecast of $10.97. Jefferies Group currently has a “Buy” rating and a $206.00 target price on the stock. Jefferies Group also issued estimates for Humana’s FY2018 earnings at $11.76 EPS.

A number of other analysts have also recently commented on the stock. Wolfe Research raised shares of Humana to an “outperform” rating and set a $192.00 target price for the company in a report on Thursday, July 21st. Credit Suisse Group AG upped their target price on shares of Humana from $160.00 to $170.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. FBR & Co lowered their price objective on shares of Humana from $220.00 to $170.00 and set a “mkt perform” rating for the company in a research report on Friday, July 22nd. Royal Bank Of Canada increased their price objective on shares of Humana from $220.00 to $224.00 and gave the company an “outperform” rating in a research report on Friday, July 22nd. Finally, RBC Capital Markets reiterated a “buy” rating and set a $224.00 price objective (up previously from $220.00) on shares of Humana in a research report on Friday, July 22nd. Five investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $205.00.

Earnings History and Estimates for Humana (NYSE:HUM)

Humana (NYSE:HUM) traded up 0.82% on Thursday, reaching $202.11. 1,314,216 shares of the company traded hands. Humana has a 1-year low of $150.00 and a 1-year high of $203.95. The stock’s 50-day moving average is $177.35 and its 200-day moving average is $176.09. The stock has a market capitalization of $30.13 billion, a price-to-earnings ratio of 27.33 and a beta of 0.80.

Humana (NYSE:HUM) last released its quarterly earnings data on Friday, November 4th. The insurance provider reported $3.18 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.09 by $0.09. The company earned $13.69 billion during the quarter, compared to the consensus estimate of $13.41 billion. Humana had a net margin of 2.00% and a return on equity of 12.32%. Humana’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same period last year, the firm earned $2.16 EPS.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Thursday, January 12th will be paid a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, January 10th. This represents a $1.16 annualized dividend and a yield of 0.58%. Humana’s dividend payout ratio (DPR) is presently 15.96%.

Large investors have recently made changes to their positions in the company. NN Investment Partners Holdings N.V. boosted its position in shares of Humana by 26.9% in the second quarter. NN Investment Partners Holdings N.V. now owns 21,525 shares of the insurance provider’s stock valued at $3,872,000 after buying an additional 4,560 shares during the last quarter. Trust Co boosted its position in shares of Humana by 12.4% in the first quarter. Trust Co now owns 1,720 shares of the insurance provider’s stock valued at $315,000 after buying an additional 190 shares during the last quarter. Chevy Chase Trust Holdings Inc. boosted its position in shares of Humana by 2.6% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 128,695 shares of the insurance provider’s stock valued at $23,150,000 after buying an additional 3,307 shares during the last quarter. Exxonmobil Investment Management Inc. TX boosted its position in shares of Humana by 6.8% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 38,578 shares of the insurance provider’s stock valued at $6,939,000 after buying an additional 2,470 shares during the last quarter. Finally, Daiwa SB Investments Ltd. boosted its position in shares of Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock valued at $132,000 after buying an additional 50 shares during the last quarter. 93.94% of the stock is currently owned by institutional investors.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.